Spred is a Sprouty-related suppressor of Ras signalling
- PMID: 11493923
- DOI: 10.1038/35088082
Spred is a Sprouty-related suppressor of Ras signalling
Abstract
Cellular proliferation, and differentiation of cells in response to extracellular signals, are controlled by the signal transduction pathway of Ras, Raf and MAP (mitogen-activated protein) kinase. The mechanisms that regulate this pathway are not well known. Here we describe two structurally similar tyrosine kinase substrates, Spred-1 and Spred-2. These two proteins contain a cysteine-rich domain related to Sprouty (the SPR domain) at the carboxy terminus. In Drosophila, Sprouty inhibits the signalling by receptors of fibroblast growth factor (FGF) and epidermal growth factor (EGF) by suppressing the MAP kinase pathway. Like Sprouty, Spred inhibited growth-factor-mediated activation of MAP kinase. The Ras-MAP kinase pathway is essential in the differentiation of neuronal cells and myocytes. Expression of a dominant negative form of Spred and Spred-antibody microinjection revealed that endogenous Spred regulates differentiation in these types of cells. Spred constitutively associated with Ras but did not prevent activation of Ras or membrane translocation of Raf. Instead, Spred inhibited the activation of MAP kinase by suppressing phosphorylation and activation of Raf. Spred may represent a class of proteins that modulate Ras-Raf interaction and MAP kinase signalling.
Similar articles
-
Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation.Biochem Biophys Res Commun. 2003 Mar 21;302(4):767-72. doi: 10.1016/s0006-291x(03)00259-6. Biochem Biophys Res Commun. 2003. PMID: 12646235
-
Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.Nat Cell Biol. 2003 May;5(5):427-32. doi: 10.1038/ncb978. Nat Cell Biol. 2003. PMID: 12717443
-
Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila.Nature. 2001 May 17;411(6835):330-4. doi: 10.1038/35077122. Nature. 2001. PMID: 11357138
-
The Sprouty/Spred family as tumor suppressors: Coming of age.Cancer Sci. 2019 May;110(5):1525-1535. doi: 10.1111/cas.13999. Epub 2019 Apr 23. Cancer Sci. 2019. PMID: 30874331 Free PMC article. Review.
-
Ras/Raf signalling and emerging pharmacotherapeutic targets.Expert Opin Pharmacother. 2002 Jun;3(6):709-18. doi: 10.1517/14656566.3.6.709. Expert Opin Pharmacother. 2002. PMID: 12036410 Review.
Cited by
-
Oxidized low-density lipoprotein is a common risk factor for cardiovascular diseases and gastroenterological cancers via epigenomical regulation of microRNA-210.Oncotarget. 2015 Sep 15;6(27):24105-18. doi: 10.18632/oncotarget.4152. Oncotarget. 2015. PMID: 26254226 Free PMC article.
-
Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.Cancer Sci. 2007 May;98(5):652-8. doi: 10.1111/j.1349-7006.2007.00445.x. Epub 2007 Mar 27. Cancer Sci. 2007. PMID: 17388789 Free PMC article.
-
Klf5 suppresses ERK signaling in mouse pluripotent stem cells.PLoS One. 2018 Nov 19;13(11):e0207321. doi: 10.1371/journal.pone.0207321. eCollection 2018. PLoS One. 2018. PMID: 30452437 Free PMC article.
-
1H, 13C and 15N resonance assignment of the human Spred2 EVH1 domain.J Biomol NMR. 2004 Jul;29(3):435-6. doi: 10.1023/B:JNMR.0000032526.17586.8c. J Biomol NMR. 2004. PMID: 15213456 No abstract available.
-
Spred1 and TESK1--two new interaction partners of the kinase MARKK/TAO1 that link the microtubule and actin cytoskeleton.Mol Biol Cell. 2008 Apr;19(4):1391-403. doi: 10.1091/mbc.e07-07-0730. Epub 2008 Jan 23. Mol Biol Cell. 2008. PMID: 18216281 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous